Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-37.86	98.17	157.96
Graham Fair Price	20.76	9.83	8.14
PEG	-75.25	0.78	-3.16
Price/Book	-22.79	2.72	3.53
Price/Cash Flow	65.50	-109.65	-317.87
Prices/Earnings	-44.84	33.49	60.71
Price/Sales	-36.17	27.79	43.54
Price/FCF	65.50	-109.65	-317.87
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.96	0.34	0.35
Operating Margin	2.55	0.20	0.20
ROA	42.74	0.02	0.01
ROE	0.01	0.02	39.99
ROIC	0.01	0.01	22.16
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.07	0.19	-62.99
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-0.23	0.27	14.87
EPS QOQ	-0.19	0.43	122.86
FCF QOQ	-1.49	-1.28	13.93
Revenue QOQ	-0.25	0.23	-7.39
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	141.03	114.02	-19.15
Days Sales Outstanding (DSO)	165.19	140.30	-15.07
Inventory Turnover	0.64	0.79	23.69
Debt/Capitalization	0.20	0.19	-7.29
Quick Ratio	8.41	10.56	25.56
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	14.23	14.53	2.07
Cash	9.82	9.42	-4.08
Capex	-0.69	-0.29	58.13
Free Cash Flow	-0.16	-0.36	-128.46
Revenue	1.15	1.42	23.46
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	9.26	11.71	26.47
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-10.30	-9.75	5.36
Naive Interpretation	Member

06 - Financial Health · Bad

Rating